Stoke Therapeutics Inc (STOK)
Healthcare
Biotechnology
28.90 $
-3.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Stoke Therapeutics Inc (STOK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -61 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -22 | -17 | -21 | -25 | -17 | -22 | -23 | 132 | -25 | -30 | -30 | -61 | -147 | |
| 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 1.0 | 0.4 | 0.4 | 2.3 | |
| 6.8 | 6.7 | 6.1 | 5.5 | 7.4 | 7.6 | 7.1 | 6.8 | 7.6 | 8.0 | 9.8 | 8.8 | 34 | |
| 7.2 | 7.0 | – | – | – | – | – | – | – | – | – | – | – | |
| 1.1 | -0.4 | -0.9 | -4.7 | 0.0 | 0.6 | -20 | 12 | -11 | -1.1 | 17 | -20 | -15 | |
| 0.8 | 0.4 | 0.2 | 0.0 | 0.0 | 0.1 | 0.0 | 0.2 | 0.2 | 0.1 | 0.2 | 0.4 | 0.9 | |
| 23 | 15 | 15 | 10.0 | -88 | -30 | 0.8 | 14 | -148 | 9.1 | -61 | 51 | -150 | |
| 0.0 | 0.6 | 7.3 | 1.7 | 121 | 8.2 | 0.6 | 1.4 | 0.6 | 3.1 | 92 | 84 | 180 | |
| 1.7 | -2.1 | 1.5 | -13 | 15 | -43 | -22 | 147 | -173 | -18 | 0.8 | 74 | -116 | |
| -23 | -18 | -21 | -25 | -18 | -22 | -23 | 132 | -26 | -30 | -31 | -61 | -148 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.